The complement system in NMOSD and MG: A target for therapeutic benefit?

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of leading experts discuss  the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice. The experts Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA This touchPODCAST is for HCPs only. An independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchIMMUNOLOGY